Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.

Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Abstract Text:

    ivan ischenkoIvan Ischenko,markus gubaMarkus Guba,maksim yezhelyevMaksim Yezhelyev,armine papyanArmine Papyan,gerald schmidGerald Schmid,tim greenTim Green,michael fennellMichael Fennell,karl-walter jauchKarl-Walter Jauch,christiane j brunsChristiane J Bruns,

    Tumor angiogenesis is a process that requires migration, proliferation, and differentiation of endothelial cells. We hypothesized that decrease in pancreatic tumor growth due to inhibition of Src activity is associated with the inability of Src kinase to trigger a network of such signaling processes, which finally leads to endothelial cell death and angiogenesis-restricted tumor dormancy. The therapeutic efficacy of Src kinase inhibitor AZM475271 was tested in nude mice orthotopically xenografted with L3.6pl pancreatic carcinoma cells. No liver metastases and peritoneal carcinosis were detected and a significant effect on the average pancreatic tumor burden was observed following treatment with AZM475271, which in turn correlated with a decrease in cell proliferation and an increase in apoptotic endothelial cells. AZM475271 was shown to significantly inhibit migration of human umbilical vein endothelial cells in an in vitro Boyden Chamber cell migration assay. In a rat aortic ring assay we could demonstrate as well inhibition of endothelial cell migration and sprouting following therapy with Src kinase inhibitor at similar doses. The most conclusive anti-angiogenic activity of AZM475271 was demonstrated in vivo (mouse corneal micropocket assay) by showing a marked inhibition of basic fibroblast growth factor-induced neovascularization in response to systemic administration of AZM475271. Furthermore, we could show reduced proliferation of HUVECs determined with the TACS MTT Cell Viability Assay Kit. The blockade of Src kinase significantly reduced the level of VEGF in L3.6pl medium, the effect which was found also in the cell culture supernate from HUVECs. Inhibition of Src kinase by AZM475271 also showed prevention of survival signaling from VEGF and EGF receptors. Treatment with AZM475271 resulted in VEGF - dependent inhibition of tyrosine phosphorylation of FAK. HUVECs were also examined using propidium iodide staining for cell cycle analysis by FACS. Inhibition of Src kinase promoted HUVEC apoptosis in a dose-dependent manner. Taken together, our results suggest that the Src kinase inhibitor AZM475271, in addition to its effects on tumor cells, suppresses tumor growth and metastasis in vitro and in vivo potentially also by anti-angiogenic mechanisms.

    Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Publishing Authors By Initials

    i ischenkoI Ischenko,m gubaM Guba,m yezhelyevM Yezhelyev,a papyanA Papyan,g schmidG Schmid,t greenT Green,m fennellM Fennell,kw jauchKW Jauch,cj brunsCJ Bruns,

    For similar enzymes and coenzymes: enzymes: transferases: phosphotransferases: phosphotransferases (alcohol group acceptor): protein kinases: protein-tyrosine kinases: src-family kinases research abstracts see: enzymes and coenzymes: enzymes: transferases: phosphotransferases: phosphotransferases (alcohol group acceptor): protein kinases: protein-tyrosine kinases: src-family kinases research

    PUBMED ID PMID:

    MEDLINE DATE:

    Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: Angiogenesis

    VOLUME: 10

    Page Numbers: 167-82

    Journal Abbreviation: Angiogenesis

    ISSN: 0969-6970

    DAY: 8

    MONTH: 05

    YEAR: 2007

    Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9814575

    Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Keywords Mesh Terms:

    KEYWORDS: src-Family Kinases

    MESH TERMS: metabolism

    Chemical & Substance for Abstract: Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer. Information

    Substance Name: src-Family Kinases

    Registry Number: EC 2.7.1.112

    Grant and Affiliation Information for Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer.

    AFFILIATION: Department of Surgery, University of Munich-Grosshadern LMU, Marchioninistr. 15, Munich, Bavaria, 81377, Germany. ivan.ischenko@med.uni-muenchen.de

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Angiogenesis

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Effect of Src kinase inhibition on metastasis and tumor angiogenesis in human pancreatic cancer Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News